Sale!

CAV3 Gene Rippling Muscle Disease Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CAV3 gene rippling muscle disease genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the CAV3 gene, which are associated with the development of rippling muscle disease (RMD). RMD is a rare genetic disorder characterized by muscle stiffness, muscle mounding, and rippling muscle contractions that occur without muscle degeneration. These symptoms are due to mutations in the CAV3 gene, which encodes caveolin-3, a protein crucial for the normal functioning of muscle cells.

The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the CAV3 gene. The accuracy and specificity of this test make it an invaluable tool for confirming a diagnosis of rippling muscle disease, thereby facilitating appropriate management and treatment strategies for affected individuals.

The cost of the CAV3 gene rippling muscle disease genetic test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the CAV3 gene. By opting for this test, patients and healthcare providers can gain critical insights into the genetic underpinnings of rippling muscle disease, enabling targeted interventions and informed decision-making regarding the patient’s health management.

Description

CAV3 Gene Rippling Muscle Disease Genetic Test

Test Name: CAV3 Gene Rippling Muscle Disease Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CAV3 Gene Rippling Muscle Disease NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CAV3 Gene Rippling Muscle Disease.

Test Details:

CAV3 gene rippling muscle disease (RMD) is a rare genetic disorder characterized by muscle stiffness and rippling contractions. It is caused by mutations in the CAV3 gene, which provides instructions for producing a protein called caveolin-3.

To diagnose CAV3 gene rippling muscle disease, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput DNA sequencing technology that allows for the rapid and cost-effective sequencing of large amounts of genetic material.

The NGS genetic test for CAV3 gene RMD involves obtaining a DNA sample, usually through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variants in the CAV3 gene.

The results of the test can confirm the presence of CAV3 gene mutations, which are indicative of rippling muscle disease. This genetic test is useful in diagnosing CAV3 gene rippling muscle disease, as it can detect even rare mutations that may not be identified through other testing methods.

It can also help determine the specific genetic variant causing the disease, which can aid in prognosis and treatment planning.

It is important to note that genetic testing for CAV3 gene rippling muscle disease should be performed by a qualified healthcare professional or a genetic counselor, who can interpret the results and provide appropriate genetic counseling and guidance.

Test Name	CAV3 Gene Rippling muscle disease Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CAV3 Gene Rippling muscle disease NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CAV3 Gene Rippling muscle disease
Test Details	CAV3 gene rippling muscle disease (RMD) is a rare genetic disorder characterized by muscle stiffness and rippling contractions. It is caused by mutations in the CAV3 gene, which provides instructions for producing a protein called caveolin-3. To diagnose CAV3 gene rippling muscle disease, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput DNA sequencing technology that allows for the rapid and cost-effective sequencing of large amounts of genetic material. The NGS genetic test for CAV3 gene RMD involves obtaining a DNA sample, usually through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variants in the CAV3 gene. The results of the test can confirm the presence of CAV3 gene mutations, which are indicative of rippling muscle disease. This genetic test is useful in diagnosing CAV3 gene rippling muscle disease, as it can detect even rare mutations that may not be identified through other testing methods. It can also help determine the specific genetic variant causing the disease, which can aid in prognosis and treatment planning. It is important to note that genetic testing for CAV3 gene rippling muscle disease should be performed by a qualified healthcare professional or a genetic counselor, who can interpret the results and provide appropriate genetic counseling and guidance.